Current drug treatment of hyperlipidemia in older adults.

about

Primary prevention of cardiovascular disease in older adults in China.Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention.

P2860

Q42365602-234DB31E-57A2-45BD-8DE0-8F073C871D6D Q52149033-5D826139-7BEC-4259-B6A5-8B634B20A0EF

P2860

Current drug treatment of hyperlipidemia in older adults.

Item

http://www.wikidata.org/entity/Q38338437

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Current drug treatment of hyperlipidemia in older adults.

@en

type

Item

label

Current drug treatment of hyperlipidemia in older adults.

@en

prefLabel

Current drug treatment of hyperlipidemia in older adults.

@en

P1476

Current drug treatment of hyperlipidemia in older adults

@en

P2093

Kelechi C Ogbonna

http://www.w3.org/2001/XMLSchema#string

Krista L Donohoe

http://www.w3.org/2001/XMLSchema#string

Sarah M Barden

http://www.w3.org/2001/XMLSchema#string

P2860

Fish oil administration in older adults: is there potential for adverse events? A systematic review of the literature

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

Frailty, fitness and late-life mortality in relation to chronological and biological age

Withdrawal of cerivastatin from the world market

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

P2888

s40266-015-0240-6

P304

127-138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40266-015-0240-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dave Dixon

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25637391

http://www.w3.org/2001/XMLSchema#string

P921

hyperlipidemia

Current drug treatment of hyperlipidemia in older adults.

about

P2860

P2860

Current drug treatment of hyperlipidemia in older adults.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921